Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial

European Respiratory Journal

Volumn 14, Issue 1, 1999, Pages 12-18

  Pizzichini, E ^a   Leff, J A ^b   Reiss, T F ^b   Hendeles, L ^c   Boulet, L P ^d   Wei, L X ^b   Efthimiadis, A E ^a   Zhang, J ^b   Hargreave, F E ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Airway inflammation; Asthma; Cysteinyl leukotriene receptor antagonists; Montelukast; Sputum eosinophils

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE; LEUKOTRIENE RECEPTOR; MONTELUKAST;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; EOSINOPHILIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SPUTUM CYTODIAGNOSIS;

ACETATES; ADULT; ASTHMA; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; PULMONARY EOSINOPHILIA; QUINOLINES; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT DISEASES; SAFETY; SPUTUM; TREATMENT OUTCOME;

EID: 0032866048     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14a04.x     Document Type: Article

References (33)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033-1039.
2. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy patients. Am Rev Respir Dis 1993; 147: 1126-1131.
3. Gauvreau GM, Doctor J, Watson RM, Jordana M, O'Byrne PM. Effect of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 1996; 154: 1267-1271.
4. Gibson PG, Wong BJO, Hepperle MJE, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1992; 22: 525-532.
5. Gibson PG, Girgis-Gabardo A, Morris MM, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989; 44: 693-699.
6. Djukanovic R, Roche WR, Wilson JW, et al State of the art: mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
7. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994; 55: 183-191.
8. 4 administration in the guinea pig. Am J Respir Crit Care Med 1996; 154: 850-857.
9. 4-receptor antagonist. Clinical Allergy 1990; 15: 411-418.
10. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993; 341: 989-990.
11. 4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 1997; 155: 1247-1253.
12. Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ, Westcott JY. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152: 897-905.
13. Kane GC, Pollice M, Kim CJ, et al. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings. J Allergy Clin Immunol 1996; 97: 646-654.
14. Reiss TF, Sorkness CA, Stricker W, et al. Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic patients treated with and without inhaled corticosteroids. Thorax 1997; 52: 45-48.
15. 4-receptor antagonism in the airways of patients with asthma. Clin Pharmacol Ther 1997; 61: 83-92.
16. Noonan MJ, Chervinsky P, Brandon M, et al., for the Montelukast Asthma Study Group. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Eur Respir J 1998; 11: 1232-1239.
17. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB, for the Montelukast Clinical Research Study Group. Montelukast, a once daily leukotriene receptor antagonist in the treatment of chronic asthma a multicenter, randomized, double-blind trial. Arch Intern Med 1998; 158: 1213-1220.
18. Leff JA, Busse WW, Pearlman D, et al. Treatment of mild asthma and exercise-induced bronchoconstriction with montelukast, a leukotriene receptor antagonist. N Engl J Med 1998; 339: 147-152.
19. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
20. Claman DM, Boushev HA, Liu J, Wong H, Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic patients. J Allergy Clin Immunol 1994; 94: 861-869.
21. Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 1995; 25: 127-132.
22. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
23. Pizzichini E, Pizzichini MM, Kidney JC, et al. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J 1998; 111: 828-834.
24. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646-651.
25. Crapo RO, Hankinson JL, Irvin C. Standardization of spirometry. Am J Respir Crit Care Med 1995; 1562: 1102-1136.
26. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-268.
27. Pizzichini E, Pizzichini MMM, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and ECP in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544.
28. Hargreave FE, Pizzichini MMM, Pizzichini E. Assessment of airway inflammation. In: Barnes PJ, Grunstein MM, Leff J, Wooilcock A, eds. Asthma. Vol 2. New York, Raven Press, 1997; pp. 1433-1450.
29. Anderson B. Regression towards the mean. In: Anderson B, ed. Methodological Errors in Medical Research. Cambridge, MA, Blackwell Scientific Publications, 1990; pp. 98-109.
30. Di Franco A, Bacci E, Cianchetti S, et al. Effect of inhaled steroids on sputum eosinophil count in naive asthmatic patients. Am J Respir Crit Care Med 1996; 153: A293.
31. Turner MO, Johnston PR, Pizzichini E, Pizzichini MM, Hussack PA, Hargreave FE. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial. Can Respir J 1998: 5: 261-268.
32. Pizzichini MM, Pizzichini E, Clelland L, et al. Prednisone dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13: 15-21.
33. Pizzichini MMM, Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155: 1501-1508.